Mobivity (MFON) 10-Q 14 Nov 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2023	Nov. 14, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2023
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	000-53851
Entity Registrant Name	Mobivity Holdings Corp.
Entity Central Index Key	0001447380
Entity Tax Identification Number	26-3439095
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	3133 West Frye Road, # 215
Entity Address, City or Town	Chandler
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85226
City Area Code	(877)
Local Phone Number	282-7660
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		67,949,709

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash	$ 457,934	$ 426,740
Accounts receivable, net of allowance for doubtful accounts $24,381 and $34,446, respectively	373,980	1,081,183
Other current assets	241,424	195,017
Total current assets	1,073,338	1,702,940
Right to use lease assets	825,041	981,896
Intangible assets and software development costs, net	78,244	194,772
Other assets	118,215	137,917
TOTAL ASSETS	2,094,838	3,017,525
Current liabilities
Accounts payable	3,492,562	3,412,612
Accrued interest	653,431	443,448
Accrued and deferred personnel compensation	111,610	569,347
Deferred revenue and customer deposits	218,552	902,727
Operating lease liability, current	269,815	251,665
Other current liabilities	15,505	49,541
Total current liabilities	6,967,713	8,373,128
Non-current liabilities
Operating lease liability	731,764	936,924
Total non-current liabilities	4,222,668	3,449,306
Total liabilities	11,190,381	11,822,434
Stockholders’ deficit
Common stock, $0.001 par value; 100,000,000 shares authorized; 67,949,709 and 61,311,155, shares issued and outstanding	67,950	61,311
Equity payable	100,862	324,799
Additional paid-in capital	117,138,356	108,806,353
Accumulated other comprehensive loss	22,227	(100,963)
Accumulated deficit	(126,424,938)	(117,896,409)
Total stockholders’ deficit	(9,095,543)	(8,804,909)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	2,094,838	3,017,525
Related Party [Member]
Current liabilities
Notes payable, net - current maturities	2,191,875	2,711,171
Non-current liabilities
Notes payable, net - long term	3,461,472	2,481,290
Nonrelated Party [Member]
Current liabilities
Notes payable, net - current maturities	14,363	32,617
Non-current liabilities
Notes payable, net - long term	$ 29,432	$ 31,092

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 24,381	$ 34,446
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	67,949,709	61,311,155
Common stock, shares outstanding	67,949,709	61,311,155

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenues
Revenues	$ 1,633,071	$ 1,890,437	$ 5,375,724	$ 5,787,168
Cost of revenues	1,160,880	1,806,022	3,598,661	4,183,719
Gross profit	472,191	84,415	1,777,063	1,603,449
Operating expenses
General and administrative	2,292,623	983,428	4,907,882	3,088,588
Sales and marketing	708,398	614,600	2,002,529	1,778,371
Engineering, research, and development	968,546	784,804	2,507,264	2,360,863
Impairment of intangible asset		238,143		238,143
Depreciation and amortization	30,418	118,317	130,902	353,050
Total operating expenses	3,999,985	2,739,292	9,548,577	7,819,015
Loss from operations	(3,527,794)	(2,654,877)	(7,771,514)	(6,215,566)
Other income/(expense)
Loss of settlement of debt			(10,857)
Interest expense	(237,376)	(193,501)	(720,265)	(520,454)
Settlement Losses	(13,000)		(25,500)
Foreign currency gain	(102)	(339)	(393)	2,470
Total other income/(expense)	(250,478)	(193,840)	(757,015)	(517,984)
Loss before income taxes	(3,778,272)	(2,848,717)	(8,528,529)	(6,733,550)
Income tax expense
Net loss	(3,778,272)	(2,848,717)	(8,528,529)	(6,733,550)
Other comprehensive loss, net of income tax
Foreign currency translation adjustments	91,825	(76,228)	123,190	(76,862)
Comprehensive loss	$ (3,686,447)	$ (2,924,945)	$ (8,405,339)	$ (6,810,412)
Net loss per share:
Basic	$ (0.06)	$ (0.05)	$ (0.13)	$ (0.12)
Diluted	$ (0.06)	$ (0.05)	$ (0.13)	$ (0.12)
Weighted average number of shares:
Basic	66,785,952	60,297,083	64,878,021	58,544,432
Diluted	66,785,952	60,297,083	64,878,021	58,544,432

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Equity Payable [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2021	$ 55,411	$ 100,862	$ 102,446,921	$ (52,088)	$ (107,835,287)	$ (5,284,181)
Beginning balance, shares at Dec. 31, 2021	55,410,695
Issuance of common stock for warrant exercise	$ 3,188		2,547,364			2,550,552
Issuance of common stock for warrant exercise, shares	3,188,190
Issuance of common stock for settlement of interest payable on related party debt			6,201			6,201
Issuance of common stock for settlement of interest payable on related party debt, shares
Stock based compensation			589,650			589,650
Foreign currency translation adjustment				(12,895)		(12,895)
Net loss					(1,933,099)	(1,933,099)
Ending balance, value at Mar. 31, 2022	$ 58,599	100,862	105,590,136	(64,983)	(109,768,386)	(4,083,772)
Ending balance, shares at Mar. 31, 2022	58,598,885
Beginning balance, value at Dec. 31, 2021	$ 55,411	100,862	102,446,921	(52,088)	(107,835,287)	(5,284,181)
Beginning balance, shares at Dec. 31, 2021	55,410,695
Foreign currency translation adjustment						(76,862)
Net loss						(6,733,550)
Ending balance, value at Sep. 30, 2022	$ 61,311	100,862	108,273,597	(128,950)	(114,568,837)	(6,262,017)
Ending balance, shares at Sep. 30, 2022	61,311,155
Beginning balance, value at Mar. 31, 2022	$ 58,599	100,862	105,590,136	(64,983)	(109,768,386)	(4,083,772)
Beginning balance, shares at Mar. 31, 2022	58,598,885
Stock based compensation			211,775			211,775
Foreign currency translation adjustment				12,261		12,261
Net loss					(1,951,734)	(1,951,734)
Issuance of common stock for PIPE financing	$ 1,062		848,937			849,999
Issuance of common stock for PIPE financing, shares	1,062,500
Fair market value of options issued with related party debt			48,654			48,654
Ending balance, value at Jun. 30, 2022	$ 59,661	100,862	106,699,502	(52,722)	(111,720,120)	(4,912,817)
Ending balance, shares at Jun. 30, 2022	59,661,385
Issuance of common stock for settlement of interest payable on related party debt	$ 150		164,021			164,171
Issuance of common stock for settlement of interest payable on related party debt, shares	149,770
Stock based compensation			192,959			192,959
Foreign currency translation adjustment				(76,228)		(76,228)
Net loss					(2,848,717)	(2,848,717)
Issuance of common stock for PIPE financing	$ 1,500		1,198,501			1,200,001
Issuance of common stock for PIPE financing, shares	1,500,000
Fair market value of options issued with related party debt			18,614			18,614
Ending balance, value at Sep. 30, 2022	$ 61,311	100,862	108,273,597	(128,950)	(114,568,837)	(6,262,017)
Ending balance, shares at Sep. 30, 2022	61,311,155
Beginning balance, value at Dec. 31, 2022	$ 61,311	324,799	108,806,353	(100,963)	(117,896,409)	(8,804,909)
Beginning balance, shares at Dec. 31, 2022	61,311,155
Issuance of common stock for warrant exercise	$ 3,587		3,583,900			3,587,487
Issuance of common stock for warrant exercise, shares	3,587,487
Issuance of common stock for settlement of interest payable on related party debt	$ 164	(7,713)	223,773			216,224
Issuance of common stock for settlement of interest payable on related party debt, shares	163,757
Stock based compensation			810,157			810,157
Foreign currency translation adjustment				31,502		31,502
Net loss					(2,478,175)	(2,478,175)
RSU’s issued - termination of a director’s service	$ 545		(545)
RSU's issued - termination of a director's service, shares	545,012
Ending balance, value at Mar. 31, 2023	$ 65,607	317,086	113,423,638	(69,461)	(120,374,584)	(6,637,714)
Ending balance, shares at Mar. 31, 2023	65,607,411
Beginning balance, value at Dec. 31, 2022	$ 61,311	324,799	108,806,353	(100,963)	(117,896,409)	(8,804,909)
Beginning balance, shares at Dec. 31, 2022	61,311,155
Foreign currency translation adjustment						123,190
Net loss						(8,528,529)
Ending balance, value at Sep. 30, 2023	$ 67,950	100,862	117,138,356	22,227	(126,424,938)	(9,095,543)
Ending balance, shares at Sep. 30, 2023	67,949,709
Beginning balance, value at Mar. 31, 2023	$ 65,607	317,086	113,423,638	(69,461)	(120,374,584)	(6,637,714)
Beginning balance, shares at Mar. 31, 2023	65,607,411
Issuance of common stock for settlement of interest payable on related party debt	$ 191	(9,768)	216,033			206,456
Issuance of common stock for settlement of interest payable on related party debt, shares	190,156
Stock based compensation			228,577			228,577
Foreign currency translation adjustment				(137)		(137)
Net loss					(2,272,082)	(2,272,082)
Ending balance, value at Jun. 30, 2023	$ 65,798	307,318	113,868,248	(69,598)	(122,646,666)	(8,474,900)
Ending balance, shares at Jun. 30, 2023	65,797,567
Issuance of common stock for warrant exercise	$ 1,961		1,606,039			1,608,000
Issuance of common stock for warrant exercise, shares	1,960,976
Issuance of common stock for settlement of interest payable on related party debt	$ 191	(206,456)	206,265
Issuance of common stock for settlement of interest payable on related party debt, shares	191,166
Stock based compensation			1,429,341			1,429,341
Foreign currency translation adjustment				91,825		91,825
Net loss					(3,778,272)	(3,778,272)
Fair market value of options issued with related party debt			28,463			28,463
Ending balance, value at Sep. 30, 2023	$ 67,950	$ 100,862	$ 117,138,356	$ 22,227	$ (126,424,938)	$ (9,095,543)
Ending balance, shares at Sep. 30, 2023	67,949,709

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
OPERATING ACTIVITIES
Net loss	$ (8,528,529)	$ (6,733,550)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on Settlement of Debt - related party	10,857
Bad debt expense	24,143	45,685
Stock-based compensation	2,468,075	994,384
Intangible Asset Impariment		238,143
Depreciation and amortization expense	162,209	353,050
Amortization of Debt Discount	89,349	83,334
Increase (decrease) in cash resulting from changes in:
Accounts receivable	683,060	(337,347)
Other current assets	9,634	(17,148)
Operating lease assets/liabilities		(15,029)
Other assets	(13,250)
Accounts payable	79,950	(184,859)
Prepaid Expenses	(46,231)
Accrued interest	621,806	432,959
Accrued and deferred personnel compensation	(457,687)	(195,975)
Other liabilities - current	(34,036)	133,167
Lease Operating Assets	(30,155)
Deferred revenue and customer deposits	(684,175)	236,827
Net cash used in operating activities	(5,644,980)	(4,966,359)
INVESTING ACTIVITIES
Purchases of equipment	(18,252)	(18,712)
Cash paid for patent activities	(6,300)
Capitalized software development cost		(12,030)
Net cash used in investing activities	(24,552)	(30,742)
FINANCING ACTIVITIES
Payments on notes payable	(20,004)	(29,145)
Proceeds from Related Party Debt	400,000	800,000
Proceeds from conversion of common stock warrants	5,195,487	2,550,552
Proceeds from PIPE funding		2,050,000
Net cash provided by (used in) financing activities	5,575,483	5,371,407
Effect of foreign currency translation on cash flow	125,243	(92,985)
Net Change in cash	31,194	281,321
Cash at beginning of period	426,740	735,424
Cash at end of period	457,934	1,016,745
Supplemental disclosure
Interest Paid
Fair Value of Options issued with related party debt	28,463	73,469
Shares issued for settlement of debt - related party	411,823	161,750
Shares issued for stock payable for settlement of debt - related party	223,937
Par Value pf RSU’s issued - termiation of director’s service	$ 545

Nature of Operations and Basis

Nature of Operations and Basis of Presentation	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations and Basis of Presentation	1. Nature of Operations and Basis of Presentation Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven mobile marketing campaigns. Our proprietary platforms, consisting of software available to phones, tablets, PCs, and Point of Sale (“POS”) systems, allow resellers, brands, and enterprises to market their products and services to consumers through text messages sent directly to consumers via mobile phones, mobile smartphone applications, and dynamically printed receipt content. On November 14, 2018, we completed the acquisition of certain operating assets relating to Belly, Inc.’s proprietary digital customer loyalty platform, including client contracts, accounts receivable, and intellectual property. We generate revenue by charging the resellers, brands, and enterprises a per-message transactional fee, through fixed or variable software licensing fees, or via advertising fees. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and disclosures required by GAAP for annual financial statements. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on April 3, 2023. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of our condensed consolidated financial statements as of September 30, 2023, and for the three and nine months ended September 30, 2023 and 2022. The results of operations for the three and nine months ended September 30, 2023 are not necessarily indicative of the operating results for the full year ending December 31, 2023.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Management believes that these estimates are reasonable; however, actual results may differ from these estimates. Reclassifications Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications did not affect previously reported net losses. Acquisitions We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill. Cash We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts. Accounts Receivable, Allowance for Doubtful Accounts and Concentrations Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate. As of September 30, 2023, and December 31, 2022, we recorded an allowance for doubtful accounts of $ 24,381 34,446 Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit. We conducted our annual impairment tests of goodwill as of December 31, 2022. As a result of these tests, we had a total impairment charge of $ 963,659 Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, non-compete agreements, and software development costs. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one year twenty years The Company’s evaluation of its goodwill and intangible assets resulted in no Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the Financial Accounting Standards Board (“FASB”) guidance for the costs of computer software to be sold, leased, or otherwise marketed (Accounting Standards Codification subtopic 985-20, Costs of Software to Be Sold, Leased, or Marketed, or “ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established, and such costs are determined to be recoverable. The technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are canceled or abandoned are charged to product development expenses in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four-month The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development assets resulted in no Impairment of Long-Lived Assets We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate. Foreign Currency Translation The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of ASC subtopic 830-10, Foreign Currency Matters . Revenue Recognition and Concentrations Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month-to-month basis with no contractual term and fees are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue. Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“ASC 606”), is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition guidance. The Company adopted this standard effective January 1, 2018, applying the modified retrospective method. Upon adoption, the Company discontinued revenue deferral under the sell-through model and commenced recording revenue upon delivery to distributors, net of estimated returns. Generally, the new standard results in earlier recognition of revenues. We determine revenue recognition under ASC 606 through the following steps: ● identification of the contract, or contracts, with a customer; ● identification of the performance obligations in the contract; ● identification of the transaction price; ● allocation of the transaction price to the performance obligations in the contract; and ● recognition of revenue when, or as, we satisfy a performance obligation. During the nine months ended September 30, 2023 and 2022, two 52 50 Comprehensive Income (Loss) Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at a comprehensive loss. For the three months ended September 30, 2023 and 2022 , the comprehensive loss was$ 3,686,447 2,924,945 8,405,339 6,810,412 Stock-based Compensation We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period. Research and Development Expenditures Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials. Advertising Expense Direct advertising costs are expensed as incurred and consist primarily of trade shows, sales enablement, content creation, paid engagement and other direct costs. Advertising expense was $ 169,549 315,540 Income Taxes We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained. Net Loss Per Common Share Basic net loss per share excludes any dilutive effects of options, shares subject to repurchase, and warrants. Diluted net loss per share includes the impact of potentially dilutive securities. During the three and nine months ended September 30, 2023 and 2022, we had securities outstanding which could potentially dilute basic earnings per share in the future. Stock based compensation, stock options and warrants were excluded from the computation of diluted net loss per share when their effect would have been anti-dilutive. Recent Accounting Pronouncements Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following is a summary of recent accounting developments. In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). ASU 2020-06 requires that the if-converted method of computing diluted Earnings per Share. The Company adopted ASU 2020-06 on January 1, 2022.

Going Concern

Going Concern	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	3. Going Concern We had $ 457,934 8,528,529 5,644,980 6,733,550 4,966,359 3.6 1.6 As shown in the accompanying financial statements, the Company has incurred net losses from operations resulting in an accumulated deficit of $ 126.4

Goodwill and Purchased Intangib

Goodwill and Purchased Intangibles	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Purchased Intangibles	4. Goodwill and Purchased Intangibles Goodwill The carrying value of goodwill at each of September 30, 2023 and December 31, 2022 was $ 0 The following table presents details of our purchased intangible assets as of September 30, 2023 and December 31, 2022: Intangible assets Schedule of Goodwill and Intangible Assets Balance at Additions Impairments Amortization Fx and Balance at Patents and trademarks $ 52,698 $ 6,300 $ — $ (5,444 ) $ 1,555 $ 55,109 Customer and merchant relationships 30,690 — — $ (18,414 ) — 12,276 Trade names 8,050 — — $ (4,831 ) — 3,219 $ 91,438 $ 6,300 $ — $ (28,689 ) $ 1,555 $ 70,604 The intangible assets are being amortized on a straight-line basis over their estimated useful lives of one year twenty years Amortization expense for intangible assets was $ 28,689 107,211 Amortization expense for intangible assets was $ 10,747 35,724 The estimated future amortization expense of our intangible assets as of September 30, 2023 is as follows: Schedule of Finite Lived Intangible Assets Future Amortization Expense Year ending December 31, Amount 2023 $ 9,193 2024 13,526 2025 5,778 2026 5,778 2027 5,778 Thereafter 30,551 Total $ 70,604

Software Development Costs

Software Development Costs	9 Months Ended
	Sep. 30, 2023
Research and Development [Abstract]
Software Development Costs	5. Software Development Costs The Company has capitalized certain costs for software developed or obtained for internal use during the application development stage as it relates to specific contracts. The amounts capitalized include external direct costs of services used in developing internal-use software and for payroll and payroll-related costs of employees directly associated with the development activities. The following table presents details of our software development costs as of September 30, 2023 and December 31, 2022: Schedule of Software Development Costs Balance at Additions Amortization Balance at Software Development Costs $ 103,334 $ — $ (95,694 ) $ 7,640 $ 103,334 $ — $ (95,694 ) $ 7,640 Software development costs are being amortized on a straight-line basis over their estimated useful life of two years Amortization expense for software development costs was $ 18,120 61,764 Amortization expense for software development costs was $ 95,694 207,027 The estimated future amortization expense of software development costs as of September 30, 2023 is as follows: Schedule of Finite Lived Intangible Assets Future Amortization Expense Year ending December 31, Amount 2023 $ 3,134 2024 4,506 2025 — 2026 — 2027 — Thereafter — Total $ 7,640

Operating Lease Assets

Operating Lease Assets	9 Months Ended
	Sep. 30, 2023
Operating Lease Assets
Operating Lease Assets	6. Operating Lease Assets The Company entered into a lease agreement on February 1, 2021, for 8,898 25,953 28,733 50 110,000 110,000 825,041 1,001,579 The following are additional details related to leases recorded on our balance sheet as of September 30, 2023: Schedule of Additional Details Related to Leases Leases Classification Balance at Assets Current Operating lease assets Operating lease assets $ — Noncurrent Operating lease assets Noncurrent operating lease assets $ 825,041 Total lease assets $ 825,041 Liabilities Current Operating lease liabilities Operating lease liabilities $ 269,815 Noncurrent Operating lease liabilities Noncurrent operating lease liabilities $ 731,764 Total lease liabilities $ 1,001,579 The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term, and weighted average discount rate: Schedule of Lessee, Operating Lease Liability Year ending December 31, 2023 $ 81,194 2024 330,894 2025 337,568 2026 344,241 2027 28,734 Thereafter — Total future lease payments 1,122,631 Less: imputed interest (121,052 ) Total $ 1,001,579 Schedule of Lease Cost Weighted Average Remaining Lease Term (years) Operating leases 3.58 Weighted Average Discount Rate Operating leases 6.75 %

Notes Payable and Interest Expe

Notes Payable and Interest Expense	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Notes Payable and Interest Expense	7. Notes Payable and Interest Expense The following table presents details of our notes payable as of September 30, 2023 and December 31, 2022: Schedule of Debt Facility Maturity Interest Rate Balance at Balance at ACOA Note February 1, 2024 — 14,363 34,231 TD Bank December 31, 2023 — 29,432 29,478 Related Party Note various 15 % 5,653,347 5,192,461 Total Debt 5,697,142 5,256,170 Less current portion (2,206,238 ) (2,743,788 ) Long-term debt, net of current portion $ 3,490,904 $ 2,512,382 ACOA Note On November 6, 2017, Livelenz (a wholly-owned subsidiary of the Company), entered into an amendment of the original agreement dated December 2, 2014, with the Atlantic Canada Opportunities Agency (“ACOA”). Under this agreement, the note will mature, and the commitments will terminate on February 1, 2024. The monthly principal payment amount of $ 3,000 3,500 4,000 4,500 2,215 During the nine months ended September 30, 2023 we repaid $ 20,004 TD Bank Loan On April 22, 2020, we entered into a commitment loan with TD Bank under the Canadian Emergency Business Account (“CEBA”), in the principal aggregate amount of $ 40,000 0 no 33 67 Related Party Notes Secured Promissory Notes On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with Thomas Akin, one of the Company’s directors (the “Lender”). The Credit Agreement was amended on November 11, 2022. The Company can borrow up to $ 6,000,000 The Credit Facility is secured by all of our tangible and intangible assets including intellectual property. This loan bears interest on the unpaid balance at the rate of fifteen percent ( 15 1.67 the Company has agreed to issue to the Lender additional warrants entitling the Lender to purchase a number of shares of the Company’s common stock equal to twenty percent (20%) of the amount of the advances made divided by the volume-weighted average price over the 30 trading days preceding the advance (the “VWAP”). Each warrant will be exercisable over a three-year period at an exercise price equal to the VWAP Under the original terms of the Credit Agreement, the Company was to begin repaying the principal amount, plus accrued interest, in 24 15 6,000,000 1.08 On January 31, 2023, the Company then entered into Amendment No. 1 (the “Amendment”), which amends our existing Credit Facility Agreement [1] On August 22, 2023, The Company took a draw of an additional $ 150,000 On September 20, 2023, The Company took a draw of an additional $ 250,000 During the nine months ended September 30, 2023, a total of $ 591,880 391,139 362,335 10,315 89,349 During the nine months period ending September 30, 2023, the Company issued warrants to purchase an aggregate of 121,808 28,463 As of September 30, 2023, the Company had drawn a total of $ 5,573,125 589,345 191,653 Unsecured Promissory Note On July 1, 2021, we entered into UP Notes in the aggregate principal amount of $ 271,875 15 2 no 33,017 On January 31, 2023, the Lender agreed to postpone the 24-month repayment period During the nine months ended September 30, 2023, a total of $ 30,926 20,504 18,987 542 As of September 30, 2023, the Company had an outstanding principal balance of $ 271,875 65,952 Interest Expense Interest expense was $ 237,376 193,501 Interest expense was $ 720,265 520,454

Stockholders_ Equity

Stockholders’ Equity	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Stockholders’ Equity	8. Stockholders’ Equity Common Stock and Equity Payable 2022 On February 9, 2022, 17 3,188,190 0.80 2,550,552 3,188,190 1.50 three 382,048 On June 29, 2022, the Company received private investment funds to purchase 1,062,500 0.80 850,000 1,062,500 1.50 three On August 24, 2022, the Company received private investment funds to purchase 1,500,000 0.80 1,200,000 1,500,000 1.50 three During the nine months ended September 30, 2022 a total of $ 161,750 149,770 2023 On January 31, 2023 a total of 545,012 no On March 27, 2023 a total of 154,106 166,432 44,325 On March 27, 2023 a total of 9,651 10,423 2,757 On March 31, 2023 a total of $ 195,171 180,715 10,315 On March 31, 2023 a total of $ 10,196 9,441 542 During March, 15 3,587,487 1.00 3,587,487 1,792,745 2.00 577,000 63 0.3216 On June 30, 2023 a total of $ 196,148 181,620 On June 30, 2023 a total of $ 10,309 9,546 During August and September of 2023, 18 1,960,976 .82 1,608,000 3,921,952 .82 1,146,562 63 73 0.21 0.40 During the nine months ended September 30, 2023 a total of 553,279 As of the nine months ended September 30, 2023 we had an equity payable balance of $ 100,862 Stock-based Plans Stock Option Activity The following table summarizes stock option activity for the nine months ended September 30, 2023. Share Based Payment Arrangement Options Activity Options Outstanding at December 31, 2021 6,246,466 Granted 1,375,000 Exercised — Forfeited/canceled (330,623 ) Expired (599,627 ) Outstanding at December 31, 2022 6,691,216 Granted 2,645,000 Exercised — Forfeited/canceled (79,165 ) Expired (1,340,384 ) Outstanding at September 30, 2023 7,916,667 2022 On March 29, 2022, the Company granted one 150,000 0.8289 25 36 72.33 0.54 81,035 On May 16, 2022, the Company granted three 45,000 0.97 25 36 73.45 0.642608 28,917 On September 22, 2022, the Company granted one 1,000,000 0.98 25 36 76.15 0.697499 697,499 2023 On May 11, 2023 the Company granted three 295,000 0.98 25 36 75.76 0.705183 208,029 On July 14, 2023 the Company granted one 1,000,000 0.85 25 36 74.55 0.5590 605,383 On July 17, 2023 the Company granted one 700,000 0.79 25 36 74.57 0.5713 396,441 On August 25, 2023 he Company granted four 650,000 0.65 25 36 64.81 0.4257 285,773 Stock-Based Compensation Expense from Stock Options and Warrants The impact on our results of operations of recording stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 were as follows: Schedule of Stock-based Compensation Expense 2023 2022 2023 2022 Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 General and administrative $ 62,599 $ 65,800 $ 181,382 $ 571,462 Sales and marketing 108,348 20,972 248,790 56,183 Engineering, research, and development 46,830 41,185 119,334 171,734 Total $ 217,777 $ 127,957 $ 549,506 $ 799,379 Valuation Assumptions The fair value of each stock option award was calculated on the date of the grant using the Black-Scholes option pricing model. The following weighted average assumptions were used for the nine months ended September 30, 2023 and 2022. Schedule of Stock Options Valuation Assumptions Nine Months Ended September 30, 2023 2022 Risk-free interest rate 3.99 % 2.47 % Expected life (years) 7.50 5.90 Expected dividend yield — % — % Expected volatility 73.47 % 69.23 % The risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock options. The expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on the historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of the Company’s stock-based awards. The dividend yield assumption is based on our history of not paying dividends and no future expectations of dividend payouts. The expected volatility in 2023 and 2022 is based on the historical publicly traded price of our common stock. Restricted stock units The following table summarizes restricted stock unit activity under our stock-based plans for the year ended December 31, 2022 and for the nine months ended September 30, 2023: Schedule of Restricted Stock Unit Activity Shares Outstanding at December 31, 2021 1,685,141 Awarded 244,792 Released — Canceled/forfeited/expired — Outstanding at December 31, 2022 1,929,933 Awarded 243,048 Released (545,012 ) Canceled/forfeited/expired — Outstanding at September 30, 2023 1,627,969 Expected to vest at September 30, 2023 1,627,969 Vested at September 30, 2023 1,526,405 Unvested at September 30, 2023 — Unrecognized expense at September 30, 2023 $ — 2022 On March 29, 2022, the company granted four 78,420 65,002 0.829 On May 16, 2022, the company granted four 54,168 65,002 1.20 On September 30, 2022, the company granted four 65,100 65,002 0.9985 During the nine months ended September 30, 2022, the Company recorded $ 195,005 2023 On March 31, 2023, the company grated granted four 61,342 65,002 1.05 On June 30, 2023, the company granted four 80,160 65,003 0.81 On September 30, 2023, the company granted four 101,564 65,001 0.64 In the nine months ended September 30, 2023, the Company recorded $ 195,006 Stock Based Compensation from Restricted Stock The impact on our results of operations of recording stock-based compensation expense for restricted stock units for the three and nine months ended September 30, 2023 and 2022 was as follows: Schedule of Stock-based Compensation Expense 2023 2022 2023 2022 Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 General and administrative $ 65,001 $ 65,002 $ 195,006 $ 195,005 Sales and marketing $ — $ — $ — $ — Total $ 65,001 $ 65,002 $ 195,006 $ 195,005 As of September 30, 2023, there was no Warrants The following table summarizes investor warrants as of September 30, 2023 and the years ended December 31, 2022 and 2021: Schedule of Investor Warrants Shares Weighted Average Exercise Price Weighted Outstanding at December 31, 2021 3,246,690 $ 2.26 3.59 Granted 6,089,398 $ — — Exercised (3,188,190 ) $ — — Canceled/forfeited/expired — $ — — Outstanding at December 31, 2022 6,147,898 $ 1.45 2.27 Granted 5,715,697 $ — — Exercised (5,548,463 ) $ — — Canceled/forfeited/expired — $ — — Outstanding at September 30, 2023 6,315,132 $ 1.62 2.50 2022 On February 9, 2022, 17 3,188,190 0.80 2,550,553 3,188,190 1.50 three 382,048 On June 29, 2022, six 1,062,500 1.50 1,062,500 0.80 850,000 On August 24, 2022, five 1,500,000 1.50 1,500,000 0.80 1,200,000 2023 During March 2023, 15 3,587,487 1.00 3,557,487 3,921,952 2.00 577,000 63 0.3216 During August and September of 2023, 18 1,906,976 .82 3,557,487 1,793,745 .82 1,146,047 72 0.2922

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	9. Fair Value Measurements Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the authoritative guidance establishes a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs other than the quoted prices in active markets that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which requires us to develop our own assumptions. This hierarchy requires companies to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. On a recurring basis, we measure certain financial assets and liabilities at fair value. The following table presents assets that are measured and recognized at fair value as of September 30, 2023 on a recurring and non-recurring basis: Schedule of Fair Value Measurements Recurring and Nonrecurring Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ — $ — Intangibles, net (non-recurring) $ — $ — $ 78,244 $ — The following table presents assets that are measured and recognized at fair value as of December 31, 2022 on a recurring and non-recurring basis: Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ — $ — Intangibles, net (non-recurring) $ — $ — $ 194,772 $ —

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	10. Commitments and Contingencies Litigation The company had a pending legal proceeding related to a Telephone Consumer Protection Act (“TCPA”) violation. This is a putative class action complaint alleging that the defendant initiated telephone solicitations through text messages in violation of the Florida Telephone Solicitation Act, Fla. Stat. § 501.059 five 25,500 Operating Lease As described in Note 6, the Company has a lease agreement for 8,898 25,953 28,733 50 825,041 1,001,579

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
Related Party Transactions	11. Related Party Transactions Secured Promissory Notes On June 30, 2021, we entered into a Credit Facility Agreement with Thomas Akin, one of the Company’s directors (the “Lender”). The Credit Facility Agreement was amended on November 11, 2022 to allow the Company to borrow up to $ 6,000,000 Unsecured Promissory Note On July 1, 2021, we entered into UP Notes in the aggregate principal amount of $ 271,875 15 For more details regarding the two related party transactions, please refer to Note 7 - Notes Payable and Interest Expense. Related Party Warrant Exercise On March 2, 2023, Thomas Akin exercised his common stock purchase warrant for 749,987 1.00 749,987 374,994 2.00 three 120,598 63 0.3216 On February 7, 2023, Talkot Fund LP exercised their common stock purchase warrant for 750,000 1.00 750,000 375,000 2.00 three 120,600 63 0.3216 On August 7, 2023, Thomas Akin exercised his common stock purchase warrant for 426,830 .82 350,000 853,660 .82 three 178,136 64 0.2087 On August 7, 2023, Talkot Fund LP exercised their common stock purchase warrant for 426,830 .82 350,000 853,660 .82 three 178,136 64 0.2087

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	12. Subsequent Events The Company has discontinued the sale and operation of the Belly loyalty card platform. The last date of operation was October 15, 2023. On November 10, 2023 three shareholders purchased convertible notes from the Company in the amount of $ 400,000 8 0.50 666,668 0.60 three

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Management believes that these estimates are reasonable; however, actual results may differ from these estimates.
Reclassifications	Reclassifications Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications did not affect previously reported net losses.
Acquisitions	Acquisitions We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill.
Cash	Cash We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts.
Accounts Receivable, Allowance for Doubtful Accounts and Concentrations	Accounts Receivable, Allowance for Doubtful Accounts and Concentrations Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate. As of September 30, 2023, and December 31, 2022, we recorded an allowance for doubtful accounts of $ 24,381 34,446
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit. We conducted our annual impairment tests of goodwill as of December 31, 2022. As a result of these tests, we had a total impairment charge of $ 963,659 Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, non-compete agreements, and software development costs. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one year twenty years The Company’s evaluation of its goodwill and intangible assets resulted in no
Software Development Costs	Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the Financial Accounting Standards Board (“FASB”) guidance for the costs of computer software to be sold, leased, or otherwise marketed (Accounting Standards Codification subtopic 985-20, Costs of Software to Be Sold, Leased, or Marketed, or “ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established, and such costs are determined to be recoverable. The technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are canceled or abandoned are charged to product development expenses in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four-month The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development assets resulted in no
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate.
Foreign Currency Translation	Foreign Currency Translation The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of ASC subtopic 830-10, Foreign Currency Matters .
Revenue Recognition and Concentrations	Revenue Recognition and Concentrations Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month-to-month basis with no contractual term and fees are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue. Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“ASC 606”), is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition guidance. The Company adopted this standard effective January 1, 2018, applying the modified retrospective method. Upon adoption, the Company discontinued revenue deferral under the sell-through model and commenced recording revenue upon delivery to distributors, net of estimated returns. Generally, the new standard results in earlier recognition of revenues. We determine revenue recognition under ASC 606 through the following steps: ● identification of the contract, or contracts, with a customer; ● identification of the performance obligations in the contract; ● identification of the transaction price; ● allocation of the transaction price to the performance obligations in the contract; and ● recognition of revenue when, or as, we satisfy a performance obligation. During the nine months ended September 30, 2023 and 2022, two 52 50
Comprehensive Income (Loss)	Comprehensive Income (Loss) Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at a comprehensive loss. For the three months ended September 30, 2023 and 2022 , the comprehensive loss was$ 3,686,447 2,924,945 8,405,339 6,810,412
Stock-based Compensation	Stock-based Compensation We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period.
Research and Development Expenditures	Research and Development Expenditures Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials.
Advertising Expense	Advertising Expense Direct advertising costs are expensed as incurred and consist primarily of trade shows, sales enablement, content creation, paid engagement and other direct costs. Advertising expense was $ 169,549 315,540
Income Taxes	Income Taxes We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained.
Net Loss Per Common Share	Net Loss Per Common Share Basic net loss per share excludes any dilutive effects of options, shares subject to repurchase, and warrants. Diluted net loss per share includes the impact of potentially dilutive securities. During the three and nine months ended September 30, 2023 and 2022, we had securities outstanding which could potentially dilute basic earnings per share in the future. Stock based compensation, stock options and warrants were excluded from the computation of diluted net loss per share when their effect would have been anti-dilutive.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following is a summary of recent accounting developments. In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). ASU 2020-06 requires that the if-converted method of computing diluted Earnings per Share. The Company adopted ASU 2020-06 on January 1, 2022.

Goodwill and Purchased Intang_2

Goodwill and Purchased Intangibles (Tables)	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill and Intangible Assets	The following table presents details of our purchased intangible assets as of September 30, 2023 and December 31, 2022: Intangible assets Schedule of Goodwill and Intangible Assets Balance at Additions Impairments Amortization Fx and Balance at Patents and trademarks $ 52,698 $ 6,300 $ — $ (5,444 ) $ 1,555 $ 55,109 Customer and merchant relationships 30,690 — — $ (18,414 ) — 12,276 Trade names 8,050 — — $ (4,831 ) — 3,219 $ 91,438 $ 6,300 $ — $ (28,689 ) $ 1,555 $ 70,604
Schedule of Finite Lived Intangible Assets Future Amortization Expense	The estimated future amortization expense of our intangible assets as of September 30, 2023 is as follows: Schedule of Finite Lived Intangible Assets Future Amortization Expense Year ending December 31, Amount 2023 $ 9,193 2024 13,526 2025 5,778 2026 5,778 2027 5,778 Thereafter 30,551 Total $ 70,604

Software Development Costs (Tab

Software Development Costs (Tables)	9 Months Ended
	Sep. 30, 2023
Finite-Lived Intangible Assets [Line Items]
Schedule of Software Development Costs	The following table presents details of our software development costs as of September 30, 2023 and December 31, 2022: Schedule of Software Development Costs Balance at Additions Amortization Balance at Software Development Costs $ 103,334 $ — $ (95,694 ) $ 7,640 $ 103,334 $ — $ (95,694 ) $ 7,640
Schedule of Finite Lived Intangible Assets Future Amortization Expense	The estimated future amortization expense of our intangible assets as of September 30, 2023 is as follows: Schedule of Finite Lived Intangible Assets Future Amortization Expense Year ending December 31, Amount 2023 $ 9,193 2024 13,526 2025 5,778 2026 5,778 2027 5,778 Thereafter 30,551 Total $ 70,604
Software and Software Development Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Schedule of Finite Lived Intangible Assets Future Amortization Expense	The estimated future amortization expense of software development costs as of September 30, 2023 is as follows: Schedule of Finite Lived Intangible Assets Future Amortization Expense Year ending December 31, Amount 2023 $ 3,134 2024 4,506 2025 — 2026 — 2027 — Thereafter — Total $ 7,640

Operating Lease Assets (Tables)

Operating Lease Assets (Tables)	9 Months Ended
	Sep. 30, 2023
Operating Lease Assets
Schedule of Additional Details Related to Leases	The following are additional details related to leases recorded on our balance sheet as of September 30, 2023: Schedule of Additional Details Related to Leases Leases Classification Balance at Assets Current Operating lease assets Operating lease assets $ — Noncurrent Operating lease assets Noncurrent operating lease assets $ 825,041 Total lease assets $ 825,041 Liabilities Current Operating lease liabilities Operating lease liabilities $ 269,815 Noncurrent Operating lease liabilities Noncurrent operating lease liabilities $ 731,764 Total lease liabilities $ 1,001,579
Schedule of Lessee, Operating Lease Liability	The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term, and weighted average discount rate: Schedule of Lessee, Operating Lease Liability Year ending December 31, 2023 $ 81,194 2024 330,894 2025 337,568 2026 344,241 2027 28,734 Thereafter — Total future lease payments 1,122,631 Less: imputed interest (121,052 ) Total $ 1,001,579
Schedule of Lease Cost	Schedule of Lease Cost Weighted Average Remaining Lease Term (years) Operating leases 3.58 Weighted Average Discount Rate Operating leases 6.75 %

Notes Payable and Interest Ex_2

Notes Payable and Interest Expense (Tables)	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Schedule of Debt	The following table presents details of our notes payable as of September 30, 2023 and December 31, 2022: Schedule of Debt Facility Maturity Interest Rate Balance at Balance at ACOA Note February 1, 2024 — 14,363 34,231 TD Bank December 31, 2023 — 29,432 29,478 Related Party Note various 15 % 5,653,347 5,192,461 Total Debt 5,697,142 5,256,170 Less current portion (2,206,238 ) (2,743,788 ) Long-term debt, net of current portion $ 3,490,904 $ 2,512,382

Stockholders_ Equity (Tables)

Stockholders’ Equity (Tables)	9 Months Ended
	Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share Based Payment Arrangement Options Activity	The following table summarizes stock option activity for the nine months ended September 30, 2023. Share Based Payment Arrangement Options Activity Options Outstanding at December 31, 2021 6,246,466 Granted 1,375,000 Exercised — Forfeited/canceled (330,623 ) Expired (599,627 ) Outstanding at December 31, 2022 6,691,216 Granted 2,645,000 Exercised — Forfeited/canceled (79,165 ) Expired (1,340,384 ) Outstanding at September 30, 2023 7,916,667
Schedule of Stock Options Valuation Assumptions	The fair value of each stock option award was calculated on the date of the grant using the Black-Scholes option pricing model. The following weighted average assumptions were used for the nine months ended September 30, 2023 and 2022. Schedule of Stock Options Valuation Assumptions Nine Months Ended September 30, 2023 2022 Risk-free interest rate 3.99 % 2.47 % Expected life (years) 7.50 5.90 Expected dividend yield — % — % Expected volatility 73.47 % 69.23 %
Schedule of Restricted Stock Unit Activity	The following table summarizes restricted stock unit activity under our stock-based plans for the year ended December 31, 2022 and for the nine months ended September 30, 2023: Schedule of Restricted Stock Unit Activity Shares Outstanding at December 31, 2021 1,685,141 Awarded 244,792 Released — Canceled/forfeited/expired — Outstanding at December 31, 2022 1,929,933 Awarded 243,048 Released (545,012 ) Canceled/forfeited/expired — Outstanding at September 30, 2023 1,627,969 Expected to vest at September 30, 2023 1,627,969 Vested at September 30, 2023 1,526,405 Unvested at September 30, 2023 — Unrecognized expense at September 30, 2023 $ —
Schedule of Investor Warrants	The following table summarizes investor warrants as of September 30, 2023 and the years ended December 31, 2022 and 2021: Schedule of Investor Warrants Shares Weighted Average Exercise Price Weighted Outstanding at December 31, 2021 3,246,690 $ 2.26 3.59 Granted 6,089,398 $ — — Exercised (3,188,190 ) $ — — Canceled/forfeited/expired — $ — — Outstanding at December 31, 2022 6,147,898 $ 1.45 2.27 Granted 5,715,697 $ — — Exercised (5,548,463 ) $ — — Canceled/forfeited/expired — $ — — Outstanding at September 30, 2023 6,315,132 $ 1.62 2.50
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Stock-based Compensation Expense	The impact on our results of operations of recording stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 were as follows: Schedule of Stock-based Compensation Expense 2023 2022 2023 2022 Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 General and administrative $ 62,599 $ 65,800 $ 181,382 $ 571,462 Sales and marketing 108,348 20,972 248,790 56,183 Engineering, research, and development 46,830 41,185 119,334 171,734 Total $ 217,777 $ 127,957 $ 549,506 $ 799,379
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Stock-based Compensation Expense	The impact on our results of operations of recording stock-based compensation expense for restricted stock units for the three and nine months ended September 30, 2023 and 2022 was as follows: Schedule of Stock-based Compensation Expense 2023 2022 2023 2022 Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 General and administrative $ 65,001 $ 65,002 $ 195,006 $ 195,005 Sales and marketing $ — $ — $ — $ — Total $ 65,001 $ 65,002 $ 195,006 $ 195,005

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value Measurements Recurring and Nonrecurring	The following table presents assets that are measured and recognized at fair value as of September 30, 2023 on a recurring and non-recurring basis: Schedule of Fair Value Measurements Recurring and Nonrecurring Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ — $ — Intangibles, net (non-recurring) $ — $ — $ 78,244 $ — The following table presents assets that are measured and recognized at fair value as of December 31, 2022 on a recurring and non-recurring basis: Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ — $ — Intangibles, net (non-recurring) $ — $ — $ 194,772 $ —

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Product Information [Line Items]
Accounts receivable, allowance for doubtful accounts	$ 24,381		$ 24,381		$ 34,446
Goodwill, Impairment loss					$ 963,659
Finite-lived intangible asset, useful life (year)	2 years		2 years
Finite-lived intangible asset, useful life (year)				$ 238,143
Comprehensive loss	$ 3,686,447	$ 2,924,945	8,405,339	6,810,412
Advertising expense			$ 169,549	$ 315,540
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Product Information [Line Items]
Number of major customers			52%	50%
Goodwill And Intangible Assets [Member]
Product Information [Line Items]
Finite-lived intangible asset, useful life (year)			$ 0	$ 0
Computer Software, Intangible Asset [Member]
Product Information [Line Items]
Finite-lived intangible asset, useful life (year)	24 months		24 months
Finite-lived intangible asset, useful life (year)	$ 0	$ 0
Minimum [Member]
Product Information [Line Items]
Finite-lived intangible asset, useful life (year)	1 year		1 year
Maximum [Member]
Product Information [Line Items]
Finite-lived intangible asset, useful life (year)	20 years		20 years

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended						9 Months Ended
	Aug. 30, 2023	Feb. 28, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash, cash equivalents, and federal funds sold			$ 457,934						$ 457,934
Net loss			3,778,272	$ 2,272,082	$ 2,478,175	$ 2,848,717	$ 1,951,734	$ 1,933,099	8,528,529	$ 6,733,550
Net cash used in operating activities									5,644,980	$ 4,966,359
Proceeds from warrant exercises	$ 1,600,000	$ 3,600,000
Accumulated deficit			$ 126,424,938						$ 126,424,938		$ 117,896,409

Schedule of Goodwill and Intang

Schedule of Goodwill and Intangible Assets (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Beginning balance			$ 91,438
Additions			6,300
Impairments		$ 238,143		$ 238,143
Amortization	(10,747)	$ (35,724)	(28,689)	$ (107,211)
Fx and Other			1,555
Ending balance	70,604		70,604
Patents and Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Beginning balance			52,698
Additions			6,300
Impairments
Amortization			(5,444)
Fx and Other			1,555
Ending balance	55,109		55,109
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Beginning balance			30,690
Additions
Impairments
Amortization			(18,414)
Fx and Other
Ending balance	12,276		12,276
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Beginning balance			8,050
Additions
Impairments
Amortization			(4,831)
Fx and Other
Ending balance	$ 3,219		$ 3,219

Schedule of Finite Lived Intang

Schedule of Finite Lived Intangible Assets Future Amortization Expense (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
2023	$ 9,193
2024	13,526
2025	5,778
2026	5,778
2027	5,778
Thereafter	30,551
Total	70,604	$ 91,438
Software and Software Development Costs [Member]
Finite-Lived Intangible Assets [Line Items]
2023	3,134
2024	4,506
2025
2026
2027
Thereafter
Total	$ 7,640

Goodwill and Purchased Intang_3

Goodwill and Purchased Intangibles (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Goodwill	$ 0		$ 0		$ 0
Finite-lived intangible asset, useful life (year)	2 years		2 years
Amortization of intangible assets	$ 10,747	$ 35,724	$ 28,689	$ 107,211
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (year)	1 year		1 year
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (year)	20 years		20 years

Schedule of Software Developmen

Schedule of Software Development Costs (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Capitalized computer software net			$ 103,334
Additions
Amortization			(95,694)
Capitalized computer software net	$ 7,640		7,640
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Assets [Line Items]
Capitalized computer software net			103,334
Additions
Amortization	(18,120)	$ (61,764)	(95,694)	$ (207,027)
Capitalized computer software net	$ 7,640		$ 7,640

Software Development Costs (Det

Software Development Costs (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	2 years		2 years
Capitalized computer software, amortization			$ 95,694
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	24 months		24 months
Capitalized computer software, amortization	$ 18,120	$ 61,764	$ 95,694	$ 207,027

Schedule of Additional Details

Schedule of Additional Details Related to Leases (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Operating Lease Assets
Operating lease assets, Current
Operating lease assets, Non-current	825,041
Operating lease assets	825,041	$ 981,896
Operating lease liabilities, Current	269,815	251,665
Operating lease liabilities, Non-current	731,764	$ 936,924
Operating lease liabilities	$ 1,001,579

Schedule of Lessee, Operating L

Schedule of Lessee, Operating Lease Liability (Details)	Sep. 30, 2023 USD ($)
Operating Lease Assets
2023	$ 81,194
2024	330,894
2025	337,568
2026	344,241
2027	28,734
Thereafter
Total future lease payments	1,122,631
Less: imputed interest	(121,052)
Total	$ 1,001,579

Schedule of Lease Cost (Details

Schedule of Lease Cost (Details)	Sep. 30, 2023
Operating Lease Assets
Weighted average remaining lease term (years) operating leases (year)	3 years 6 months 29 days
Weighted average discount rate, operating leases	6.75%

Operating Lease Assets (Details

Operating Lease Assets (Details Narrative)	Feb. 01, 2021 USD ($) ft²	Sep. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Lessee, Lease, Description [Line Items]
Operating lease assets		$ 825,041	$ 981,896
Operating lease liability		1,001,579
Lease Ending January 2027 [Member]
Lessee, Lease, Description [Line Items]
Area of real estate property | ft²	8,898
Represents abatement percentage of operating lease for lessee	50%
Deposit assets	$ 110,000
Fixed assets contributed by lessor	110,000
Operating lease assets		825,041
Operating lease liability		$ 1,001,579
Lease Ending January 2027 [Member] | Minimum [Member]
Lessee, Lease, Description [Line Items]
Monthly rental expense	25,953
Lease Ending January 2027 [Member] | Maximum [Member]
Lessee, Lease, Description [Line Items]
Monthly rental expense	$ 28,733

Schedule of Debt (Details)

Schedule of Debt (Details) - USD ($)	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Apr. 22, 2020
Short-Term Debt [Line Items]
Debt and lease obligation, total	$ 5,697,142	$ 5,256,170
Long term debt current	(2,206,238)	(2,743,788)
Long-term debt, net of current portion	$ 3,490,904	2,512,382
ACOA Note [Member]
Short-Term Debt [Line Items]
Maturity	Feb. 01, 2024
Debt and lease obligation, total	$ 14,363	34,231
TD Bank [Member]
Short-Term Debt [Line Items]
Maturity	Dec. 31, 2023
Debt and lease obligation, total	$ 29,432	29,478
Interest Rate			0%
Related Party Note [Member]
Short-Term Debt [Line Items]
Debt and lease obligation, total	$ 5,653,347	$ 5,192,461
Interest Rate	15%

Notes Payable and Interest Ex_3

Notes Payable and Interest Expense (Details Narrative)									3 Months Ended		9 Months Ended
	Jan. 31, 2023	Aug. 01, 2022 CAD ($)	Aug. 01, 2021 CAD ($)	Jul. 01, 2021 USD ($) shares	Jun. 30, 2021 USD ($) $ / shares	Apr. 22, 2020 USD ($)	Nov. 01, 2019 CAD ($)	Nov. 06, 2017 CAD ($)	Sep. 30, 2023 USD ($) shares	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) shares	Sep. 30, 2023 CAD ($) shares	Sep. 30, 2022 USD ($)	Sep. 20, 2023 USD ($)	Aug. 22, 2023 USD ($)	Nov. 11, 2022 USD ($) $ / shares	Aug. 24, 2022 $ / shares	Jun. 29, 2022 $ / shares	Feb. 09, 2022 $ / shares
Short-Term Debt [Line Items]
Class of warrant or right, exercise price of warrants or Rrights | $ / shares																	$ 0.80	$ 0.80	$ 0.80
Interest expense, debt									$ 237,376	$ 193,501	$ 720,265		$ 520,454
Discounts Debt											$ 89,349		$ 83,334
Director [Member] | Credit Agreement [Member]
Short-Term Debt [Line Items]
Additional draw														$ 250,000	$ 150,000
Warrants to purchase shares | shares									121,808		121,808
Fair value of warrants issued											$ 28,463
ACOA Note [Member] | Livelenz [Member]
Short-Term Debt [Line Items]
Debt instrument periodic payment		$ 4,500	$ 4,000				$ 3,500	$ 3,000			20,004	$ 2,215
TD Bank [Member]
Short-Term Debt [Line Items]
Debt instrument periodic payment						$ 0
Debt instrument face amount						$ 40,000
Interest rate						0%
Percent of loan forgiven						33%
Percent of loan repaid requirement for forgiveness						67%
Credit Agreement [Member]
Short-Term Debt [Line Items]
Interest payable current and non current									$ 589,345		589,345
Proceeds from long term lines of credit including interest											5,573,125
Debt instrument discount									191,653		191,653
Credit Agreement [Member] | Director [Member]
Short-Term Debt [Line Items]
Interest rate					15%											15%
Line of credit facility maximum borrowing capacity					$ 6,000,000											$ 6,000,000
Class of warrant or right, exercise price of warrants or Rrights | $ / shares					$ 1.67
Warrant exercisable period afte issuance of financing					the Company has agreed to issue to the Lender additional warrants entitling the Lender to purchase a number of shares of the Company’s common stock equal to twenty percent (20%) of the amount of the advances made divided by the volume-weighted average price over the 30 trading days preceding the advance (the “VWAP”). Each warrant will be exercisable over a three-year period at an exercise price equal to the VWAP
Frequency of period payment					24
Debt instrument monthly conversion of interest rate per share | $ / shares																$ 1.08
Credit Agreement [Member] | Thomas Akin [Member]
Short-Term Debt [Line Items]
Interest expense, debt											591,880
Interest payable current and non current									391,139		$ 391,139
Debt conversion converted instrument shares issued 1 | shares											362,335	362,335
Gain (loss) on settlement of debt											$ 10,315
Discounts Debt											89,349
Unsecured Promissory Notes [Member]
Short-Term Debt [Line Items]
Debt instrument face amount				$ 271,875
Interest rate				15%
Frequency of period payment	24-month repayment period
Interest expense, debt											30,926
Interest payable current and non current									65,952		$ 65,952
Debt conversion converted instrument shares issued 1 | shares											18,987	18,987
Gain (loss) on settlement of debt											$ 542
Warrants to purchase shares | shares				33,017
Proceeds from long term lines of credit including interest											271,875
Pre-payment penalty rate				2%
Payments for Commissions				$ 0
Unsecured Promissory Notes [Member] | Director [Member]
Short-Term Debt [Line Items]
Interest payable current and non current									$ 20,504		$ 20,504

Share Based Payment Arrangement

Share Based Payment Arrangement Options Activity (Details) - shares								9 Months Ended	12 Months Ended
	Aug. 25, 2023	Jul. 17, 2023	Jul. 14, 2023	May 11, 2023	Sep. 22, 2022	May 16, 2022	Mar. 29, 2022	Sep. 30, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options, Granted	650,000	700,000	1,000,000	295,000	1,000,000	45,000	150,000
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding, Beginning balance								6,691,216	6,246,466
Options, Granted								2,645,000	1,375,000
Options, Exercised
Options, Forfeited/canceled								(79,165)	(330,623)
Options, Expired								(1,340,384)	(599,627)
Options outstanding, Ending balance								7,916,667	6,691,216

Schedule of Stock-based Compens

Schedule of Stock-based Compensation Expense (Details) - USD ($)					3 Months Ended		9 Months Ended
	Aug. 07, 2023	Mar. 02, 2023	Feb. 07, 2023	Feb. 09, 2022	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Total	$ 178,136	$ 120,598	$ 120,600	$ 382,048	$ 217,777	$ 127,957	$ 549,506	$ 799,379
Restricted Stock Units (RSUs) [Member]
Total					65,001	65,002	195,006	195,005
General and Administrative Expense [Member]
Total					62,599	65,800	181,382	571,462
General and Administrative Expense [Member] | Restricted Stock Units (RSUs) [Member]
Total					65,001	65,002	195,006	195,005
Selling and Marketing Expense [Member]
Total					108,348	20,972	248,790	56,183
Selling and Marketing Expense [Member] | Restricted Stock Units (RSUs) [Member]
Total
Engineering And Research And Development Expense [Member]
Total					$ 46,830	$ 41,185	$ 119,334	$ 171,734

Schedule of Stock Options Valua

Schedule of Stock Options Valuation Assumptions (Details)											9 Months Ended
	Aug. 25, 2023	Aug. 07, 2023	Jul. 17, 2023	Jul. 14, 2023	May 11, 2023	Feb. 14, 2023	Feb. 07, 2023	Sep. 22, 2022	May 16, 2022	Mar. 29, 2022	Sep. 30, 2023	Sep. 30, 2022
Equity [Abstract]
Risk-free interest rate											3.99%	2.47%
Expected life (years) (Year)											7 years 6 months	5 years 10 months 24 days
Expected dividend yield
Expected volatility	64.81%	64%	74.57%	74.55%	75.76%	63%	63%	76.15%	73.45%	72.33%	73.47%	69.23%

Schedule of Restricted Stock Un

Schedule of Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) [Member] - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding, Beginning balance	1,929,933	1,685,141
Shares, Awarded	243,048	244,792
Shares, Released	(545,012)
Shares, Canceled/forfeited/expired
Shares outstanding, Ending balance	1,627,969	1,929,933
Shares, Expected to vest at September 30, 2023	1,627,969
Shares, Vested at September 30, 2023	1,526,405
Unvested at September 30, 2023
Unrecognized expense at September 30, 2023

Schedule of Investor Warrants (

Schedule of Investor Warrants (Details) - Investor Warrant [Member] - shares	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Class of Warrant or Right [Line Items]
Shares outstanding, Beginning balance	6,147,898	3,246,690
Weighted Average Exercise Price, Outstanding, Beginning balance	1.45	2.26
Outstanding (in shares)	2 years 6 months	2 years 3 months 7 days	3 years 7 months 2 days
Warrants, Granted	5,715,697	6,089,398
Warrants, Exercised	(5,548,463)	(3,188,190)
Warrants, Canceled/forfeited/expired
Shares outstanding, Ending balance	6,315,132	6,147,898	3,246,690
Weighted Average Exercise Price, Outstanding, Ending balance	1.62	1.45	2.26

Stockholders_ Equity (Details N

Stockholders’ Equity (Details Narrative)																		1 Months Ended				3 Months Ended					6 Months Ended	9 Months Ended		12 Months Ended
	Aug. 25, 2023 USD ($) Integer $ / shares shares	Aug. 07, 2023 USD ($) $ / shares	Jul. 17, 2023 USD ($) Integer $ / shares shares	Jul. 14, 2023 USD ($) Integer $ / shares shares	May 11, 2023 USD ($) Integer $ / shares shares	Mar. 27, 2023 USD ($) shares	Mar. 02, 2023 USD ($)	Feb. 14, 2023 $ / shares	Feb. 07, 2023 USD ($) $ / shares	Sep. 30, 2022 USD ($) Integer $ / shares shares	Sep. 22, 2022 USD ($) Integer $ / shares shares	Aug. 24, 2022 USD ($) Integer $ / shares shares	Jun. 29, 2022 USD ($) $ / shares shares	Jun. 29, 2022 Integer $ / shares shares	May 16, 2022 USD ($) Integer $ / shares shares	Mar. 29, 2022 USD ($) Integer $ / shares shares	Feb. 09, 2022 USD ($) Integer $ / shares shares	Sep. 30, 2023 USD ($) $ / shares Integer shares	Aug. 31, 2023 USD ($) $ / shares Integer shares	Mar. 31, 2023 USD ($) $ / shares Integer shares	Jan. 31, 2023 shares	Sep. 30, 2023 USD ($) $ / shares shares	Jun. 30, 2023 shares	Mar. 31, 2023 USD ($) $ / shares Integer shares	Sep. 30, 2022 USD ($) shares	Mar. 31, 2022 USD ($) shares	Jun. 30, 2023 USD ($) Integer $ / shares shares	Sep. 30, 2023 USD ($) $ / shares shares	Sep. 30, 2022 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Class of Warrant or Right [Line Items]
Number of warrant holding | Integer												5		6			17
Issuance of common stock for warrant exercise (in shares) | shares												1,500,000	1,062,500				3,188,190
Exercise price | $ / shares												$ 0.80	$ 0.80	$ 0.80			$ 0.80
Additional issuance of common stock for warrant exercise | shares																	2,550,552
Stock-based compensation expense		$ 178,136					$ 120,598		$ 120,600								$ 382,048					$ 217,777			$ 127,957			$ 549,506	$ 799,379
Issuance of common stock for warrant exercise (in shares)																						1,608,000		$ 3,587,487		$ 2,550,552
Equity amount payable																		$ 100,862				100,862						$ 100,862			$ 324,799
Number of employees, awards granted | Integer	4		1	1	3						1				3	1
Granted, shares | shares	650,000		700,000	1,000,000	295,000						1,000,000				45,000	150,000
Share-based compensation option grant per share | $ / shares	$ 0.65		$ 0.79	$ 0.85	$ 0.98						$ 0.98				$ 0.97	$ 0.8289
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage	25%		25%	25%	25%						25%				25%	25%
Share-based compensation arrangement by share-based payment award, award vesting period	36 months		36 months	36 months	36 months						36 months				36 months	36 months
Expected volatility	64.81%	64%	74.57%	74.55%	75.76%			63%	63%		76.15%				73.45%	72.33%												73.47%	69.23%
Option fair value | $ / shares	$ 0.4257	$ 0.2087	$ 0.5713	$ 0.5590	$ 0.705183			$ 0.3216	$ 0.3216		$ 0.697499				$ 0.642608	$ 0.54
Share-based compensation arrangement by share-based payment award, call option value	$ 285,773		$ 396,441	$ 605,383	$ 208,029						$ 697,499				$ 28,917	$ 81,035
Additional capital												$ 1,200,000	$ 850,000				$ 2,550,553	3,557,487	$ 3,557,487					3,557,487
Talkot Fund LP [Member]
Class of Warrant or Right [Line Items]
Stock-based compensation expense		$ 178,136
Expected volatility		64%
Option fair value | $ / shares		$ 0.2087
Related Party [Member]
Class of Warrant or Right [Line Items]
Debt instrument, shares issued | shares																												553,279
Restricted Stock Units (RSUs) [Member]
Class of Warrant or Right [Line Items]
Stock-based compensation expense																						65,001			$ 65,002			$ 195,006	$ 195,005
Share-based payment arrangement, nonvested award
Warrants [Member]
Class of Warrant or Right [Line Items]
Stock-based compensation expense																		$ 1,146,047	$ 1,146,047					577,000
John Harris [Member]
Class of Warrant or Right [Line Items]
Stock issued during period, Shares, issued for services | shares																					545,012
John Harris [Member] | Restricted Stock [Member]
Class of Warrant or Right [Line Items]
Stock-based compensation expense																								$ 0
Board of Directors [Member]
Class of Warrant or Right [Line Items]
Restricted stock expense																												195,006	$ 195,005
Board of Directors [Member] | Restricted Stock Units (RSUs) [Member]
Class of Warrant or Right [Line Items]
Number of employees, awards granted | Integer										4					4	4		4						4			4
Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period | shares										65,100					54,168	78,420		101,564						61,342			80,160
Share-based compensation arrangement by share based payment award, equity instruments other than options, grants in period, value										$ 65,002					$ 65,002	$ 65,002		$ 65,001						$ 65,002			$ 65,003
Closing stock price on date of the grant per share | $ / shares										$ 0.9985					$ 1.20	$ 0.829		$ 0.64						$ 1.05			$ 0.81
Conversion of Interest Payable to Common Stock [Member]
Class of Warrant or Right [Line Items]
Gain (loss) on settlement of interest payable																				$ 542								$ 161,750
Debt instrument, shares issued | shares																				9,441								149,770
Debt conversion, original debt, amount																				$ 10,196
Conversion of Interest Payable on Related Party Debt into Common Stock [Member]
Class of Warrant or Right [Line Items]
Debt instrument, shares issued | shares																											10,309
Number of shares equity payable for the issuance of common stock | shares																											9,546
Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Thomas Akin [Member]
Class of Warrant or Right [Line Items]
Gain (loss) on settlement of interest payable																															$ 44,325
Issuance of common stock for debt settlement (in shares) | shares						154,106
Interest Payable						$ 166,432
Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Talkot Fund LP [Member]
Class of Warrant or Right [Line Items]
Gain (loss) on settlement of interest payable																														$ 2,757
Issuance of common stock for debt settlement (in shares) | shares						9,651
Interest Payable						$ 10,423
Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Former Director [Member]
Class of Warrant or Right [Line Items]
Debt instrument, shares issued | shares																											196,148
Number of shares equity payable for the issuance of common stock | shares																											181,620
Conversion of Interest Payable to Common Stock [Member]
Class of Warrant or Right [Line Items]
Gain (loss) on settlement of interest payable																				$ 10,315
Debt instrument, shares issued | shares																				180,715
Debt conversion, original debt, amount																				$ 195,171
Common Stock [Member]
Class of Warrant or Right [Line Items]
Number of warrant holding | Integer																		18	18					15
Issuance of common stock for warrant exercise (in shares) | shares																						1,960,976		3,587,487		3,188,190
Exercise price | $ / shares												$ 0.80	$ 0.80	$ 0.80				$ 0.82	$ 0.82	$ 1		$ 0.82		$ 1				$ 0.82
Number of warrants to purchase common stock | shares												1,500,000	1,062,500	1,062,500				1,906,976	1,906,976	3,587,487		1,906,976		3,587,487				1,906,976
Issuance of common stock for debt settlement (in shares) | shares																						191,166	190,156	163,757	149,770
Issuance of common stock for warrant exercise (in shares)																						$ 1,961		$ 3,587		$ 3,188
Warrant [Member]
Class of Warrant or Right [Line Items]
Expected volatility																		72%	72%					63%
Option fair value | $ / shares																		$ 0.2922	$ 0.2922					$ 0.3216
Inducement Warrant [Member]
Class of Warrant or Right [Line Items]
Issuance of common stock for warrant exercise (in shares) | shares												1,200,000	850,000
Exercise price | $ / shares												$ 1.50	$ 1.50	$ 1.50			$ 1.50	$ 0.82	$ 0.82	$ 2		$ 0.82		$ 2				$ 0.82
Warrants and Rights Outstanding, Term												3 years	3 years	3 years			3 years
Stock-based compensation expense																		$ 1,146,562	$ 1,146,562
Number of warrants to purchase common stock | shares																		1,793,745	1,793,745	3,921,952		1,793,745		3,921,952				1,793,745
Class of warrant or right, number of securities called by warrants or rights | shares																		3,921,952	3,921,952	1,792,745		3,921,952		1,792,745				3,921,952
Inducement Warrant [Member] | Measurement Input, Price Volatility [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input																				0.63				0.63
Inducement Warrant [Member] | Measurement Input, Price Volatility [Member] | Minimum [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input																		0.63	0.63			0.63						0.63
Inducement Warrant [Member] | Measurement Input, Price Volatility [Member] | Maximum [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input																		0.73	0.73			0.73						0.73
Inducement Warrant [Member] | Option Fair Value [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input | $ / shares																				0.3216				0.3216
Inducement Warrant [Member] | Option Fair Value [Member] | Minimum [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input | $ / shares																		0.21	0.21			0.21						0.21
Inducement Warrant [Member] | Option Fair Value [Member] | Maximum [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input | $ / shares																		0.40	0.40			0.40						0.40
Inducement Warrant [Member] | Talkot Fund LP [Member]
Class of Warrant or Right [Line Items]
Exercise price | $ / shares		$ 0.82
Warrants and Rights Outstanding, Term		3 years
Inducement Warrant [Member] | Warrant [Member]
Class of Warrant or Right [Line Items]
Stock-based compensation expense																				$ 577,000
Common Stock Purchase Warrants [Member]
Class of Warrant or Right [Line Items]
Number of warrant holding | Integer																		18	18	15
Issuance of common stock for warrant exercise (in shares) | shares																		1,960,976	1,960,976	3,587,487
Exercise price | $ / shares																		$ 0.82	$ 0.82	$ 1		$ 0.82		$ 1				$ 0.82
Issuance of common stock for warrant exercise (in shares)																		$ 1,608,000	$ 1,608,000	$ 3,587,487
Common Stock Purchase Warrants [Member] | Talkot Fund LP [Member]
Class of Warrant or Right [Line Items]
Exercise price | $ / shares		$ 0.82
Additional capital		$ 350,000
New Warrants [Member]
Class of Warrant or Right [Line Items]
Exercise price | $ / shares												$ 1.50	$ 1.50	$ 1.50
Number of warrants to purchase common stock | shares												1,500,000	1,062,500	1,062,500

Schedule of Fair Value Measurem

Schedule of Fair Value Measurements Recurring and Nonrecurring (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill (non-recurring)
Intangibles, net (non-recurring)
Fair Value, Inputs, Level 1 [Member] | Fair Value, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill (non-recurring)
Intangibles, net (non-recurring)
Fair Value, Inputs, Level 2 [Member] | Fair Value, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill (non-recurring)
Intangibles, net (non-recurring)
Fair Value, Inputs, Level 3 [Member] | Fair Value, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill (non-recurring)
Intangibles, net (non-recurring)	$ 78,244	$ 194,772

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative)		3 Months Ended		9 Months Ended
	Feb. 01, 2021 USD ($) ft²	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) Integer	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)
Loss Contingencies [Line Items]
Loss contingency claims settled number | Integer				5
Settlement losses		$ 13,000		$ 25,500
Operating lease asset		825,041		825,041		$ 981,896
Operating lease liability		1,001,579		1,001,579
Lease Ending January 2027 [Member]
Loss Contingencies [Line Items]
Area of a real estate property | ft²	8,898
Represents abatement percentage of operating lease for lessee	50%
Operating lease asset		825,041		825,041
Operating lease liability		$ 1,001,579		$ 1,001,579
Lease Ending January 2027 [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Represents monthly rental expense	$ 25,953
Lease Ending January 2027 [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Represents monthly rental expense	$ 28,733

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)															1 Months Ended		3 Months Ended			9 Months Ended
	Aug. 25, 2023	Aug. 07, 2023	Jul. 17, 2023	Jul. 14, 2023	May 11, 2023	Mar. 02, 2023	Feb. 14, 2023	Feb. 07, 2023	Sep. 22, 2022	Aug. 24, 2022	Jun. 29, 2022	May 16, 2022	Mar. 29, 2022	Feb. 09, 2022	Sep. 30, 2023	Aug. 31, 2023	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Nov. 11, 2022	Jul. 01, 2021	Jun. 30, 2021
Related Party Transaction [Line Items]
Class of warrant or right exercise price of warrants or rights1										$ 0.80	$ 0.80			$ 0.80
Additional capital										$ 1,200,000	$ 850,000			$ 2,550,553	$ 3,557,487	$ 3,557,487		$ 3,557,487
Stock-based compensation expense		$ 178,136				$ 120,598		$ 120,600						$ 382,048			$ 217,777		$ 127,957	$ 549,506	$ 799,379
Expected volatility	64.81%	64%	74.57%	74.55%	75.76%		63%	63%	76.15%			73.45%	72.33%							73.47%	69.23%
Option fair value	$ 0.4257	$ 0.2087	$ 0.5713	$ 0.5590	$ 0.705183		$ 0.3216	$ 0.3216	$ 0.697499			$ 0.642608	$ 0.54
Common Stock Purchase Warrants [Member]
Related Party Transaction [Line Items]
Class of warrant or right exercise price of warrants or rights1															$ 0.82	$ 0.82	$ 0.82	$ 1		$ 0.82
Inducement Warrant [Member]
Related Party Transaction [Line Items]
Class of warrant or right exercise price of warrants or rights1										$ 1.50	$ 1.50			$ 1.50	$ 0.82	$ 0.82	$ 0.82	$ 2		$ 0.82
Class of warrant or right, number of securities called by warrants or rights															1,793,745	1,793,745	1,793,745	3,921,952		1,793,745
Warrants and rights outstanding, term										3 years	3 years			3 years
Stock-based compensation expense															$ 1,146,562	$ 1,146,562
Director [Member] | Common Stock Purchase Warrants [Member]
Related Party Transaction [Line Items]
Class of warrant or right exercised during period		426,830				749,987		750,000
Class of warrant or right exercise price of warrants or rights1		$ 0.82				$ 1		$ 1
Additional capital		$ 350,000				$ 749,987		$ 750,000
Class of warrant or right, number of securities called by warrants or rights		853,660				374,994		375,000
Director [Member] | Inducement Warrant [Member]
Related Party Transaction [Line Items]
Class of warrant or right exercise price of warrants or rights1		$ 0.82				$ 2		$ 2
Warrants and rights outstanding, term		3 years				3 years		3 years
Talkot Fund LP [Member]
Related Party Transaction [Line Items]
Stock-based compensation expense		$ 178,136
Expected volatility		64%
Option fair value		$ 0.2087
Talkot Fund LP [Member] | Common Stock Purchase Warrants [Member]
Related Party Transaction [Line Items]
Class of warrant or right exercised during period		426,830
Class of warrant or right exercise price of warrants or rights1		$ 0.82
Additional capital		$ 350,000
Talkot Fund LP [Member] | Inducement Warrant [Member]
Related Party Transaction [Line Items]
Class of warrant or right exercise price of warrants or rights1		$ 0.82
Warrants and rights outstanding, term		3 years
Credit Agreement [Member] | Director [Member]
Related Party Transaction [Line Items]
Line of credit facility maximum borrowing capacity																						$ 6,000,000		$ 6,000,000
Debt instrument interest rate stated percentage																						15%		15%
Class of warrant or right exercise price of warrants or rights1																								$ 1.67
Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Debt iinstrument face amount																							$ 271,875
Debt instrument interest rate stated percentage																							15%
Class of warrant or right, number of securities called by warrants or rights																							33,017

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Nov. 10, 2023	Aug. 24, 2022	Jun. 29, 2022	Feb. 09, 2022
Subsequent Event [Line Items]
Class of warrant or right, exercise price of warrants or Rrights		$ 0.80	$ 0.80	$ 0.80
Subsequent Event [Member] | Three Stockholders [Member]
Subsequent Event [Line Items]
Convertible notes purchased	$ 400,000
Interest Rate	8%
Conversion price per share	$ 0.50
Number of warrants to purchase, shares	666,668
Class of warrant or right, exercise price of warrants or Rrights	$ 0.60
Number of warrants exercise price term	3 years